Literature DB >> 15252055

Individual nucleotide bases, not base pairs, are critical for triggering site-specific DNA cleavage by vaccinia topoisomerase.

Ligeng Tian1, Jane M Sayer, Donald M Jerina, Stewart Shuman.   

Abstract

Vaccinia DNA topoisomerase forms a covalent DNA-(3'-phosphotyrosyl)-enzyme intermediate at a specific target site 5'-C(+5)C(+4)C(+3)T(+2)T(+1)p downward arrow N(-1) in duplex DNA. Here we study the effects of abasic lesions at individual positions of the scissile and nonscissile strands on the rate of single-turnover DNA transesterification and the cleavage-religation equilibrium. The rate of DNA incision was reduced by factors of 350, 250, 60, and 10 when abasic sites replaced the -1N, +1T, +2T, and +4C bases of the scissile strand, but abasic lesions at +5C and +3C had little or no effect. Abasic lesions in the nonscissile strand in lieu of +4G, +3G, +2A, and +1A reduced the rate of cleavage by factors of 130, 150, 10, and 5, whereas abasic lesions at +5G and -1N had no effect. The striking positional asymmetry of abasic interference on the scissile and nonscissile strands highlights the importance of individual bases, not base pairs, in promoting DNA cleavage. The rate of single-turnover DNA religation by the covalent topoisomerase-DNA complex was insensitive to abasic sites within the CCCTT sequence of the scissile strand, but an abasic lesion at the 5'-OH nucleoside (-1N) of the attacking DNA strand slowed the rate of religation by a factor of 600. Nonscissile strand abasic lesions at +1A and -1N slowed the rate of religation by factors of approximately 140 and 20, respectively, and strongly skewed the cleavage-religation equilibrium toward the covalent complex. Thus, abasic lesions immediately flanking the cleavage site act as topoisomerase poisons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15252055     DOI: 10.1074/jbc.M407376200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Major groove interactions of vaccinia Topo I provide specificity by optimally positioning the covalent phosphotyrosine linkage.

Authors:  Rajesh Nagarajan; James T Stivers
Journal:  Biochemistry       Date:  2006-05-09       Impact factor: 3.162

2.  New peptide inhibitors of type IB topoisomerases: similarities and differences vis-a-vis inhibitors of tyrosine recombinases.

Authors:  David F Fujimoto; Clemencia Pinilla; Anca M Segall
Journal:  J Mol Biol       Date:  2006-08-24       Impact factor: 5.469

3.  Chemical and traditional mutagenesis of vaccinia DNA topoisomerase provides insights to cleavage site recognition and transesterification chemistry.

Authors:  Lyudmila Yakovleva; Shengxi Chen; Sidney M Hecht; Stewart Shuman
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

Review 4.  All tangled up: how cells direct, manage and exploit topoisomerase function.

Authors:  Seychelle M Vos; Elsa M Tretter; Bryan H Schmidt; James M Berger
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-23       Impact factor: 94.444

5.  Crystal structure of a bacterial topoisomerase IB in complex with DNA reveals a secondary DNA binding site.

Authors:  Asmita Patel; Lyudmila Yakovleva; Stewart Shuman; Alfonso Mondragón
Journal:  Structure       Date:  2010-06-09       Impact factor: 5.006

6.  Chemical mutagenesis of vaccinia DNA topoisomerase lysine 167 provides insights to the catalysis of DNA transesterification.

Authors:  Lyudmila Yakovleva; Stewart Shuman
Journal:  Biochemistry       Date:  2013-01-23       Impact factor: 3.162

7.  Variola virus topoisomerase: DNA cleavage specificity and distribution of sites in Poxvirus genomes.

Authors:  Nana Minkah; Young Hwang; Kay Perry; Gregory D Van Duyne; Robert Hendrickson; Elliot J Lefkowitz; Sridhar Hannenhalli; Frederic D Bushman
Journal:  Virology       Date:  2007-04-25       Impact factor: 3.616

8.  Characterization of DNA Binding by the Isolated N-Terminal Domain of Vaccinia Virus DNA Topoisomerase IB.

Authors:  Benjamin Reed; Lyudmila Yakovleva; Stewart Shuman; Ranajeet Ghose
Journal:  Biochemistry       Date:  2017-06-19       Impact factor: 3.162

Review 9.  Structural studies of type I topoisomerases.

Authors:  Nicole M Baker; Rakhi Rajan; Alfonso Mondragón
Journal:  Nucleic Acids Res       Date:  2008-12-23       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.